The Food and Drug Administration approved Jubilant Life Sciences' new drug for the treatment of hypertension.
Supply Chain
Starting in October, Greenville (S.C.) County School District will have to pay for EpiPens, which for the past three years were shipped to the district for free, according to a local NBC affiliate.
Democratic presidential candidate Hillary Clinton is the newest political figure urging Mylan to voluntarily lower the price of its life-saving EpiPen injection, reports Reuters.
When Ann Maxwell, assistant inspector general of the Department of Health and Human Services (HHS) Office of Inspector General (OIG) testified before the Congressional Committee on Energy and Commerce's subcommittee on oversight and investigation in May of 2016, the new…
Recall activity for pharmaceutical products rose 35 percent in the second quarter of 2016 to their highest level since the third quarter of 2014, according to a new Recall Index report. It also found that medical device recall activity increased…
Advertisement
Facing large scrutiny for the high price of its EpiPen medication, Mylan promised Thursday to lower the cost patients must pay for the life-saving injection, reported The Wall Street Journal.
Oak Brook, Ill.-based Medtronic acquired medical device manufacturer HeartWare International for $1.1 billion, according to Nasdaq.
The American Medical Association joined consumers and a handful of senators in scrutinizing Mylan's extreme price hikes for its life-saving EpiPen injection.
The Food and Drug Administration granted priority review status to Clovis Oncology's experimental cancer drug.
Starting September 24, the Food and Drug Administration will require all Class II devices to be labeled with unique device identifiers.